VRAL Company to Research Lyme Treatment
By Bryan Rosner on Mar 25, 2009 in Research | comments(1)
Mar 23, 2009 Viral Genetics, Inc. a biotechnology company that discovers and develops immune-based therapies, announced it has successfully secured $75,000 in grant funding from the Turn The Corner Foundation for an upcoming Lyme disease study. Continued